Irf8通过Mertk信号调控斑马鱼骨髓增殖性肿瘤样综合征的进展
本研究利用irf8突变斑马鱼探讨Irf8在体内抑制髓系肿瘤的机制。irf8突变体存活后快速发生骨髓增殖性肿瘤(MPN)样疾病,髓系前体输出增多且可移植复发;Mertk信号在突变体造血细胞中异常激活,过表达mertk可重现该综合征,而干扰Mertk可减轻Irf8缺陷所致的髓系扩增。
要点
- Irf8在斑马鱼中进化保守,通过严格控制髓系细胞增殖与寿命发挥抑瘤作用。
- irf8突变体发生MPN样疾病,髓系前体输出增多,移植后可复发。
- Mertk信号在irf8突变体造血细胞中异常激活,干扰Mertk可减轻髓系扩增。
核心结论
- Mertk信号是Irf8介导调控髓系肿瘤进展的关键下游因子。
研究设计与样本
- 本研究为斑马鱼体内实验研究,使用irf8突变体及Tg(coro1a:mertk)转基因斑马鱼。
主要发现
- 存活的irf8突变体快速发生MPN样疾病,髓系前体输出增强,移植后疾病复发。
- irf8突变体造血细胞中多个分子显著改变,Mertk信号异常激活。
- Tg(coro1a:mertk)斑马鱼中过表达mertk可重现irf8突变体的髓系肿瘤样综合征。
- 通过吗啉代敲低或遗传破坏干扰Mertk,可减轻Irf8缺陷所致的髓系扩增表型。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Interferon regulatory factor (IRF)-8 is a critical transcription factor involved in the pathogenesis of myeloid neoplasia. However, the underlying mechanisms in vivo are not well known. Investigation of irf8-mutant zebrafish in this study indicated that Irf8 is evolutionarily conserved as an essential neoplastic suppressor through tight control of the proliferation and longevity of myeloid cells. Surviving irf8 mutants quickly developed a myeloproliferative neoplasm (MPN)-like disease with enhanced output of the myeloid precursors, which recurred after transplantation. Multiple molecules presented notable alteration and Mertk signaling was aberrantly activated in the hematopoietic cells in irf8 mutants. Transgenic mertk overexpression in Tg(coro1a:mertk) zebrafish recapitulated the myeloid neoplasia-like syndrome in irf8 mutants. Moreover, functional interference with Mertk, via morpholino knockdown or genetic disruption, attenuated the myeloid expansion phenotype caused by Irf8 deficiency. Therefore, Mertk signaling is a critical downstream player in the Irf8-mediated regulation of the progression of myeloid neoplasia. Our study extends the understanding of the mechanisms underlying leukemogenesis.
引用
- Zhao F, Shi Y, Huang Y, et al. Irf8 regulates the progression of myeloproliferative neoplasm-like syndrome via Mertk signaling in zebrafish. Leukemia. 2017. PMID: 28626217. doi:10.1038/leu.2017.189
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。